Current Cancer Drug Targets

Editor-in-Chief

Ruiwen Zhang
Center for Drug Discovery
University of Houston
3455 Cullen Blvd.
Houston, TX 77204
(USA)

Personal Subscription
Become EABM
Become Reviewer

FHIT and p53 Status and Response to Platinum-Based Treatment in Advanced Non-Small Cell Lung Cancer

Volume:8   Issue: 5
Pp: 342-348
D. L. Cortinovis, F. Andriani, A. Livio, A. Fabbri, F. Perrone, B. Marcomini, S. Pilotti, L. Mariani, P. Bidoli, E. Bajetta, L. Roz and G. Sozzi
DOI: 10.2174/156800908785133204

Targeting Angiogenesis in Renal Cell Carcinoma

Volume:8   Issue: 5
Pp: 349-358
Georgios Lainakis and Aristotle Bamias
DOI: 10.2174/156800908785133132

Molecular Targets in Gastrointestinal Stromal Tumors (GIST) Therapy

Volume:8   Issue: 5
Pp: 359-366
C. Braconi, R. Bracci and R. Cellerino
DOI: 10.2174/156800908785133169

Regulation of Cell Growth by Estrogen Signaling and Potential Targets in Thyroid Cancer

Volume:8   Issue: 5
Pp: 367-377
George G. Chen, Alexander C. Vlantis, Qiang Zeng and C. Andrew van Hasselt
DOI: 10.2174/156800908785133150

Targeting Blood Vessels for the Treatment of Non-Small Cell Lung Cancer

Volume:8   Issue: 5
Pp: 392-403
Ethan Amir, Sarah Hughes, Fiona Blackhall, Nick Thatcher, Gyula Ostoros, Jozsef Timar, Jozsef Tovari, Gabor Kovacs and Balazs Dome
DOI: 10.2174/156800908785133187

Celecoxib Upregulates Multidrug Resistance Proteins in Colon Cancer: Lack of Synergy with Standard Chemotherapy

Volume:8   Issue: 5
Pp: 414-420
A. Gradilone, F. M. Pulcinelli, L. V. Lotti, E. Trifiro, S. Martino, O. Gandini, W. Gianni, L. Frati, A. M. Agliano and P. Gazzaniga
DOI: 10.2174/156800908785133178

NUPR1 Interacts with p53, Transcriptionally Regulates p21 and Rescues Breast Epithelial Cells from Doxorubicin-Induced Genotoxic Stress

Volume:8   Issue: 5
Pp: 421-430
David W. Clark, Aparna Mitra, Rebecca A. Fillmore, Wen G. Jiang, Rajeev S. Samant, Oystein Fodstad and Lalita A. Shevde
DOI: 10.2174/156800908785133196